279 related articles for article (PubMed ID: 31568022)
1. Serum Vitamin D Deficiency Is an Independent Risk Factor for Thyroid Eye Disease.
Heisel CJ; Riddering AL; Andrews CA; Kahana A
Ophthalmic Plast Reconstr Surg; 2020; 36(1):17-20. PubMed ID: 31568022
[TBL] [Abstract][Full Text] [Related]
2. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
3. Thyroid eye disease in Eastern Province of Saudi Arabia: clinical profile and correlation with vitamin D deficiency.
Alali M; Alkulaib NS; Alkhars A; Albadri K; Al Hassan S; Elewa M; Aldairi W; Alsaqer SK; Al-Abdulqader RA; Alhammad F
Orbit; 2024 Feb; 43(1):28-32. PubMed ID: 36855900
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Thyroid Eye Disease.
Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
7. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L; Gallo D; Tanda ML; Kahaly GJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S2-S8. PubMed ID: 38054980
[TBL] [Abstract][Full Text] [Related]
8. New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review.
Mohamed A; Tzoulis P; Kossler AL; Dosiou C
J Clin Endocrinol Metab; 2023 Mar; 108(4):979-985. PubMed ID: 36251747
[TBL] [Abstract][Full Text] [Related]
9. Thyroid eye disease with choroidal folds.
Tran AQ; Zhang-Nunes SX; Cahill K; Alabiad CR; Shriver EM; Ho T; Weinberg DA; Couch SM; Schlachter DM; Nguyen J; Wester ST
Orbit; 2021 Jun; 40(3):206-214. PubMed ID: 32326785
[No Abstract] [Full Text] [Related]
10. Novel inflammatory biomarkers in thyroid eye disease.
Ueland HO; Ueland GÅ; Løvås K; Breivk LE; Thrane AS; Meling Stokland AE; Rødahl E; Husebye ES
Eur J Endocrinol; 2022 Aug; 187(2):293-300. PubMed ID: 35675127
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Graves' disease in patients with thyroid eye disease].
Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves' disease.
Li X; Wang G; Lu Z; Chen M; Tan J; Fang X
J Endocrinol Invest; 2015 Jul; 38(7):753-9. PubMed ID: 25736544
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
Meling Stokland AE; Austdal M; Nedrebø BG; Carlsen S; Hetland HB; Breivik L; Ueland HO; Watt T; Cramon PK; Løvås K; Husebye ES; Ueland GÅ
J Clin Endocrinol Metab; 2024 Feb; 109(3):827-836. PubMed ID: 37747433
[TBL] [Abstract][Full Text] [Related]
14. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis.
Patel VK; Padnick-Silver L; D'Souza S; Bhattacharya RK; Francis-Sedlak M; Holt RJ
Endocr Pract; 2022 Feb; 28(2):159-164. PubMed ID: 34781042
[TBL] [Abstract][Full Text] [Related]
16. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
[TBL] [Abstract][Full Text] [Related]
17. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.
Zhang H; Liang L; Xie Z
Endocr Pract; 2015 Mar; 21(3):258-63. PubMed ID: 25370319
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.
Poon SHL; Cheung JJ; Shih KC; Chan YK
Rev Endocr Metab Disord; 2022 Jun; 23(3):541-567. PubMed ID: 35066781
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.
Moeen Rad A; Zarei-Ghanavati S; Sabermoghaddam A; Ghavami Shahri SH; Bakhtiari E; Kiarudi MY
Int Ophthalmol; 2023 Oct; 43(10):3615-3621. PubMed ID: 37393605
[TBL] [Abstract][Full Text] [Related]
20. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
